Céline Loriot
Impact in
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism
-
- Hormonal Regulation and Hypertension
- Pituitary Gland Disorders and Treatments
Papers in
- Surgery 4
- Adrenal and Paraganglionic Tumors 4
-
- Cancer, Hypoxia, and Metabolism 4
- Cancer, Lipids, and Metabolism 1
- Co-authors
- Anne‐Paule Gimenez‐Roqueplo (5 shared papers)Judith Favier (5 shared papers)Laurence Amar (4 shared papers)Jérôme Bertherat (4 shared papers)Éric Letouzé (4 shared papers)Nelly Burnichon (3 shared papers)Nasséra Abermil (2 shared papers)Alexandre Buffet (2 shared papers)
- Journals
- Oncotarget (2 papers)Cancer Cell (1 paper)International Journal of Cancer (1 paper)Human Molecular Genetics (1 paper)American Journal Of Pathology (1 paper)
- Partner nations
- FranceUnited StatesSweden
In The Last Decade
Céline Loriot
8 papers receiving 990 citations
Hit Papers
Peers
Comparison fields: 5 of 62
- Cancer Research 696
- Endocrinology, Diabetes and Metabolism 351
- Surgery 485
- Genetics 104
- Neurology 102
Countries citing papers authored by Céline Loriot
This map shows the geographic impact of Céline Loriot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Céline Loriot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Céline Loriot more than expected).
Fields of papers citing papers by Céline Loriot
This network shows the impact of papers produced by Céline Loriot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Céline Loriot. The network helps show where Céline Loriot may publish in the future.
Co-authors
The 25 scholars most cited alongside Céline Loriot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma Hit paper breakdown → | 2013 | 551 |
| 2 | 2014 | 137 | |
| 3 | 2012 | 106 | |
| 4 | 2012 | 83 | |
| 5 | 2015 | 55 | |
| 6 | 2011 | 47 | |
| 7 | 2017 | 21 | |
| 8 | 2017 | 1 |
About Céline Loriot
Céline Loriot is a scholar working on Surgery, Cancer Research, Oncology, Molecular Biology and Genetics, having authored 8 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (4 papers), Adrenal and Paraganglionic Tumors (4 papers), Hormonal Regulation and Hypertension (2 papers), Neuroblastoma Research and Treatments (2 papers), Peptidase Inhibition and Analysis (1 paper), Cancer-related Molecular Pathways (1 paper), Cancer, Lipids, and Metabolism (1 paper) and Neurofibromatosis and Schwannoma Cases (1 paper). The work is most often cited by research in Cancer Research (696 citations), Endocrinology, Diabetes and Metabolism (351 citations), Surgery (485 citations), Genetics (104 citations) and Neurology (102 citations). Céline Loriot has collaborated with scholars based in France, United States and Sweden. Frequent co-authors include Anne‐Paule Gimenez‐Roqueplo, Judith Favier, Laurence Amar, Jérôme Bertherat, Éric Letouzé, Nelly Burnichon, Nasséra Abermil, Alexandre Buffet, Cosimo Martinelli and Mélanie Menara. Their work appears in journals such as Oncotarget, Cancer Cell, International Journal of Cancer, Human Molecular Genetics and American Journal Of Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.